220 related articles for article (PubMed ID: 19090506)
1. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals.
Pietrzak RH; Snyder PJ; Jackson CE; Olver J; Norman T; Piskulic D; Maruff P
Hum Psychopharmacol; 2009 Mar; 24(2):113-21. PubMed ID: 19090506
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological profile of cognitively impaired patients with schizophrenia.
Bozikas VP; Kosmidis MH; Kiosseoglou G; Karavatos A
Compr Psychiatry; 2006; 47(2):136-43. PubMed ID: 16490572
[TBL] [Abstract][Full Text] [Related]
3. Cognitive functioning in siblings discordant for schizophrenia.
Hughes C; Kumari V; Das M; Zachariah E; Ettinger U; Sumich A; Sharma T
Acta Psychiatr Scand; 2005 Mar; 111(3):185-92. PubMed ID: 15701102
[TBL] [Abstract][Full Text] [Related]
4. Test-retest stability of neuropsychological testing and individual differences in variability in schizophrenia outpatients.
Conway Greig T; Nicholls SS; Wexler BE; Bell MD
Psychiatry Res; 2004 Dec; 129(3):241-7. PubMed ID: 15661317
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological performance over time in people at high risk of developing schizophrenia and controls.
Whyte MC; Brett C; Harrison LK; Byrne M; Miller P; Lawrie SM; Johnstone EC
Biol Psychiatry; 2006 Apr; 59(8):730-9. PubMed ID: 16388781
[TBL] [Abstract][Full Text] [Related]
7. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cognitive performance in schizophrenia patients and healthy individuals with unsupervised clustering models.
Silver H; Shmoish M
Psychiatry Res; 2008 May; 159(1-2):167-79. PubMed ID: 18440074
[TBL] [Abstract][Full Text] [Related]
9. Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.
Michaud K; Forget H; Cohen H
Brain Cogn; 2009 Oct; 71(1):1-8. PubMed ID: 19428166
[TBL] [Abstract][Full Text] [Related]
10. An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring.
Pietrzak RH; Maruff P; Mayes LC; Roman SA; Sosa JA; Snyder PJ
Arch Clin Neuropsychol; 2008 Jul; 23(4):433-45. PubMed ID: 18448309
[TBL] [Abstract][Full Text] [Related]
11. Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect.
Badcock JC; Dragović M; Waters FA; Jablensky A
J Psychiatr Res; 2005 Jan; 39(1):11-9. PubMed ID: 15504419
[TBL] [Abstract][Full Text] [Related]
12. Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study.
Silver H; Knoll G; Isakov V; Goodman C; Finkelstein Y
J Psychiatr Res; 2005 Nov; 39(6):569-75. PubMed ID: 16157159
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia.
Halari R; Mehrotra R; Sharma T; Ng V; Kumari V
Psychiatry Res; 2006 Feb; 141(2):129-39. PubMed ID: 16427141
[TBL] [Abstract][Full Text] [Related]
14. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
[TBL] [Abstract][Full Text] [Related]
15. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity.
Heinrichs RW; Ruttan L; Zakzanis KK; Case D
Brain Cogn; 1997 Nov; 35(2):207-24. PubMed ID: 9356162
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment in spinocerebellar ataxia type 8.
Lilja A; Hämäläinen P; Kaitaranta E; Rinne R
J Neurol Sci; 2005 Oct; 237(1-2):31-8. PubMed ID: 15958266
[TBL] [Abstract][Full Text] [Related]
17. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.
Maruff P; Thomas E; Cysique L; Brew B; Collie A; Snyder P; Pietrzak RH
Arch Clin Neuropsychol; 2009 Mar; 24(2):165-78. PubMed ID: 19395350
[TBL] [Abstract][Full Text] [Related]
18. Postoperative cognitive dysfunction: true deterioration versus random variation.
Rasmussen LS; Siersma VD;
Acta Anaesthesiol Scand; 2004 Oct; 48(9):1137-43. PubMed ID: 15352960
[TBL] [Abstract][Full Text] [Related]
19. Computerized assessment of cognitive impairment in narcoleptic patients.
Ha KS; Yoo HK; Lyoo IK; Jeong DU
Acta Neurol Scand; 2007 Nov; 116(5):312-6. PubMed ID: 17854401
[TBL] [Abstract][Full Text] [Related]
20. Comparative cognitive profiles of obsessive-compulsive disorder and schizophrenia.
Martin V; Huber M; Rief W; Exner C
Arch Clin Neuropsychol; 2008 Sep; 23(5):487-500. PubMed ID: 18508232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
